Evidence map›Paper›PMID 33024154›Full record

ArticleScientific reports2020

The crystal structure of mycobacterial epoxide hydrolase A.

Eike C Schulz, Sara R Henderson, Boris Illarionov, Thomas Crosskey, Stacey M Southall, Boris Krichel, Charlotte Uetrecht, Markus Fischer, Matthias Wilmanns

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Eike C SchulzMax Planck Institute for the Structure and Dynamics of Matter, Luruper Chausee 149, 22761, Hamburg, Germany. eike.schulz@mpsd.mpg.de.
Sara R HendersonEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22603, Hamburg, Germany.
Boris IllarionovHamburg School of Food Science, Institute of Food Chemistry, Universität Hamburg, Grindelallee 117, 20146, Hamburg, Germany.
Thomas CrosskeyEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22603, Hamburg, Germany.
Stacey M SouthallEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22603, Hamburg, Germany.
Boris KrichelHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Martinistraße 52, 20251, Hamburg, Germany.
Charlotte UetrechtHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Martinistraße 52, 20251, Hamburg, Germany.
Markus FischerHamburg School of Food Science, Institute of Food Chemistry, Universität Hamburg, Grindelallee 117, 20146, Hamburg, Germany.
Matthias WilmannsEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22603, Hamburg, Germany.
European Molecular Biology Laboratory · DEUniversität Hamburg · DELeibniz Institute of Virology (LIV) · DENorwich Research Park · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human pathogen Mycobacterium tuberculosis is the causative agent of tuberculosis resulting in over 1 million fatalities every year, despite decades of research into the development of new anti-TB compounds. Unlike most other organisms M. tuberculosis has six putative genes for epoxide hydrolases (EH) of the α/β-hydrolase family with little known about their individual substrates, suggesting functional significance for these genes to the organism. Due to their role in detoxification, M. tuberculosis EH's have been identified as potential drug targets. Here, we demonstrate epoxide hydrolase activity of M. thermoresistibile epoxide hydrolase A (Mth-EphA) and report its crystal structure in complex with the inhibitor 1,3-diphenylurea at 2.0 Å resolution. Mth-EphA displays high sequence similarity to its orthologue from M. tuberculosis and generally high structural similarity to α/β-hydrolase EHs. The structure of the inhibitor bound complex reveals the geometry of the catalytic residues and the conformation of the inhibitor. Comparison to other EHs from mycobacteria allows insight into the active site plasticity with respect to substrate specificity. We speculate that mycobacterial EHs may have a narrow substrate specificity providing a potential explanation for the genetic repertoire of epoxide hydrolase genes in M. tuberculosis.

Indexed as

CrystallizationCarbanilidesEpoxide HydrolasesGenes, BacterialInactivation, MetabolicMycobacterium tuberculosisSubstrate SpecificityCarbanilidesEpoxide Hydrolases

Identifiers

PMID33024154
PMCPMC7538969
OpenAlexW3091912534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.